Atossa Therapeutics Inc.

ATOS | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.43

+$0.18 (+8.00%)

Sep 22, 2026, 12:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $22.44M

Enterprise Value $-3.65M

Beta 1.28

Average Volume 124.32K

Shares Outstanding (Diluted) 8.91M

Shares Change YoY 3.45%

Institutional Ownership 14.38%

Exchange NASDAQ

ISIN US04962H7044

Price Performance

Price Change 1M -11.4%

Price Change 3M 18.4%

Price Change 6M -58.5%

Price Change YTD -76.2%

Price Change 1Y -81.9%

Price Change 3Y -81.9%

Price Change 5Y -95.6%

1M CAGR (ann.) -4.7%

1Y CAGR (ann.) -83.0%

5Y CAGR (ann.) -46.7%

All-Time CAGR -46.4%

Valuation

PE Ratio -0.52

Forward PE N/A

PEG Ratio 0.02

Forward PEG 0.02

PS Ratio N/A

Forward PS 0.30

PB Ratio 0.84

P/FCF Ratio -0.63

P/Adj. FCF Ratio -0.58

P/OCF Ratio -0.56

EV/Sales N/A

EV/EBIT 0.12

EV/EBITDA 0.12

EV/FCF 0.10

Earnings Yield -192.9%

FCF Yield -159.4%

Adj. FCF Yield -172.0%

Financial Health

Net Cash $26.09M

Total Debt $0

Cash & Short-Term Investments $26.09M

Total Assets $32.28M

Current Ratio 5.69

Quick Ratio 5.69

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -11.04

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -7.9%

Returns

Return on Assets -116.8%

Return on Equity -103.0%

Return on Invested Capital -146.3%

Return on Capital Employed -146.3%

Return on Tangible Assets -116.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -17.2%

EPS CAGR 5Y -9.3%

EPS CAGR 10Y 44.3%

FCF CAGR 3Y -32.2%

FCF CAGR 5Y -16.9%

FCF CAGR 10Y -18.0%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 5

EPS Growth Next 3Y 125.1%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.92

EPS Growth Est (next Q) -12.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $42.50

Price Target Upside 1788.9%

Cash Flow

Operating Cash Flow $-35.77M

Free Cash Flow $-35.78M

Adj. Free Cash Flow $-38.61M

FCF Per Share -$4.02

OCF Per Share -$4.02

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-8K

Operating Income $-30.56M

EBITDA $-29.21M

Net Income $-37.71M

EPS (Diluted) -$4.34

Revenue / Employee N/A

Profit / Employee $-2.36M

Employees 16